Who
DSS, INC.
10% owner
Company insider
Files Form 4 as: 10% owner, Impact BioMedical; 10% owner, Sharing Services Global.
In numbers
- Trades disclosed
- 108
- Buys
- 56
- Sells
- 16
- Bought
- $4.1M
- Sold
- $3.3M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Apr 2020
- Last trade
- 24 Sep 2026
- Last filed
- 24 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 24 Sep 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $1,101156 at $7.06 | filing |
| 24 Sep 2026filed 24 Sep 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $1,101156 at $7.06 | filing |
| 23 Sep 2026filed 24 Sep 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $18827 at $6.95 | filing |
| 23 Sep 2026filed 24 Sep 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $18827 at $6.95 | filing |
| 22 Sep 2026filed 24 Sep 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $398723 at $0.55 | filing |
| 22 Sep 2026filed 24 Sep 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $398723 at $0.55 | filing |
| 27 May 2025filed 6 Jan 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $25K45,400 at $0.5403 | filing |
| 27 May 2025filed 6 Jan 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $25K45,400 at $0.54 | filing |
| 27 May 2025filed 27 May 2025 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $25K45,400 at $0.54 | filing |
| 22 May 2025filed 6 Jan 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $63K115,600 at $0.5491 | filing |
| 22 May 2025filed 6 Jan 2026 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $64K115,600 at $0.55 | filing |
| 22 May 2025filed 27 May 2025 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $64K115,600 at $0.55 | filing |
| 4 Apr 2025filed 7 Apr 2025 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $846K890,800 at $0.95 | filing |
| 27 Mar 2025filed 28 Mar 2025 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $119K47,681 at $2.50 | filing |
| 26 Mar 2025filed 28 Mar 2025 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $151K48,281 at $3.13 | filing |
| 26 Mar 2025filed 28 Mar 2025 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $31K9,858 at $3.15 | filing |
| 21 Mar 2025filed 28 Mar 2025 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $550K166,600 at $3.30 | filing |
| 21 Mar 2025filed 28 Mar 2025 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $550K166,600 at $3.30 | filing |
| 21 Mar 2025filed 28 Mar 2025 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Sold | $550K166,600 at $3.30 | filing |
| 20 Mar 2025filed 24 Mar 2025 | IBO Impact BioMedicalBiotechnology | SEC FORM 4 Bought | $310200 at $1.55 | filing |
News
No headline names them, or the companies they trade most, lately.